Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

NSE: JAGSNPHARM
|
Pharmaceuticals
|
S Cap
₹ 232.00
+₹6.53 (2.90%)
1D
Last updated 13 Aug, 2026, 15:29 IST

Jagsonpal Pharmaceuticals Share Price Today

As of 14 Aug 2026, Jagsonpal Pharmaceuticals share price is ₹232.00. The stock opened at ₹224.35, compared to its previous close of ₹225.47. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹223.00 to ₹232.79, with an average price of ₹227.89 for the day. Looking at its last 52-week, the stock has touched a low of ₹155.00 and a high of ₹264.50. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 31.77% over the last six months and is down 8.38% on a year-on-year basis.

₹223.00
2.90% up today
₹232.79
1D LOW
1D HIGH

Jagsonpal Pharmaceuticals Returns Calculator

Circuit
L
H
₹184.02
₹276.02
52-week
L
H
₹155.00
₹264.50

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Share Price
ISIN
INE048B01035
Sector Market Cap
₹ 1,489.68 Cr

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Jagsonpal Pharmaceuticals Financial Highlights

  • Revenue: Jagsonpal Pharmaceuticals reported revenue of ₹299.23 crore in FY26 vs ₹276.91 crore in FY25. It showed an increase of 8.06% on a yearly basis.
  • Operating Profit: Jagsonpal Pharmaceuticals reported an operating profit of ₹57.52 crore in FY26 vs ₹69.86 crore in FY25. It showed a decrease of 17.66% on a year-on-year basis.
  • Net Profit: Jagsonpal Pharmaceuticals reported a net profit of ₹43.08 crore in FY26 vs ₹55.36 crore in FY25. It showed a decrease of 22.18% on a yearly basis.

Jagsonpal Pharmaceuticals Quarterly Result Highlights

  • Jagsonpal Pharmaceuticals reported revenue of ₹85.06 crore in Jun 2026, compared with ₹67.37 crore in Mar 2026, representing an increase of 26.26% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported an operating profit of ₹17.68 crore in Jun 2026, compared with ₹11.76 crore in Mar 2026, representing an increase of 50.34% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported a profit of ₹13.19 crore in Jun 2026, compared with ₹8.76 crore in Mar 2026, reflecting an increase of 50.57% on a QoQ basis.
  • The earnings per share (EPS) of Jagsonpal Pharmaceuticals stood at ₹8.26 during Jun 2026.
Know more
Promoters
69.05%
FII
2.30%
Other DII
0.62%
Retail and other
28.03%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20252.12%
Dec 20252.12%
Mar 20262.44%
Jun 20262.30%
Mkt Cap Cr
1,489.68
P/E
32.75
P/B
5.40
ROE
15.60%
D/E
0.03
ROCE
20.59%
Div. Yield
1.77%
EPS(TTM)
6.40
Turnover
0.93
EV/EBITDA
20.06
Net Margin
0.00%
Op. Margin
0.00%
ROA
14.36%
Quick Ratio
0.00
Curr. Ratio
5.35
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Jagsonpal Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Jagsonpal Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

Jagsonpal Pharmaceuticals Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹268.72₹208.70₹236.71₹217.58
Other Income₹8.19₹9.28₹5.73₹3.43
Total Revenue₹276.91₹217.98₹242.45₹221.01
Total Expenses₹226.73₹188.11₹204.18₹194.37
Profit Before Tax₹69.86₹29.87₹34.81₹26.64
Tax₹14.50₹7.41₹8.09₹7.79
Profit After Tax₹55.36₹22.46₹26.72₹18.86
EPS - Basic₹8.26₹3.40₹10.20₹7.20
EPS - Diluted₹8.22₹3.39₹10.20₹7.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹69.86₹29.87₹34.81₹26.64
Income before WC changes₹57.92₹38.14₹44.44₹25.24
Change in Assets-₹1.48₹11.12₹9.39-₹8.62
Change in Liabilities₹7.00-₹5.58₹0.10-₹2.84
Change in WC₹5.52₹5.54₹9.50-₹11.46
Cash flow from Operations₹55.30₹35.17₹46.66₹6.91
Cash flow from Investing-₹45.15-₹24.55-₹57.67-₹25.78
Cash flow from Financing-₹11.70-₹8.91-₹0.46-₹17.55
Total Cash Flow-₹1.55₹1.71-₹11.47-₹36.42
Cash (Start of the year)₹12.76₹11.05₹22.53₹58.94
Cash (End of the year)₹11.22₹12.76₹11.05₹22.53

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹117.07₹20.30₹30.39₹55.14
Current Assets₹161.19₹196.78₹164.56₹109.08
Total Assets₹278.26₹217.08₹194.95₹164.23
Current Liabilities₹25.90₹19.13₹27.57₹26.97
Net Current Asset₹135.29₹177.65₹136.99₹82.11
Non-Current Liabilities₹12.41₹10.55₹8.49₹4.49
Equity Capital₹239.95₹187.40₹158.89₹132.76
Total Equity & Liabilities₹278.26₹217.08₹194.95₹164.23
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
46.36
Neutral
ATR (14)
10.84
Neutral
STOCH(9,6)
4.27
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
36.96
Bearish
UO(9)
41.43
Neutral
ROC(12)
-1.8
Bearish
WillR(14)
-77.29
Neutral
Period
Simple value
Exponential vaue
5D
231.74
230.51
10D
233.7
231.31
20D
228.84
230.16
50D
224.02
223.94
100D
211.31
215.15
Volume trend — traded volume by day
13 Aug0L
12 Aug1L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
Jagsonpal Pharmaceuticals Share Price
Jagsonpal Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

Jagsonpal Pharmaceuticals Share Price FAQs